Vascular closure vs manual compression after AF ablation
Part of Heart & circulation clinical trials.
This study compares two methods to close the blood vessel after a catheter ablation for atrial fibrillation (AF). It may help reduce bleeding or other problems at the access site.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a catheter ablation for atrial fibrillation (AF).
- You are 18 years old or older.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways to close the vein entry after heart ablation for AFib: the LockeT device versus manual compression. It helps find which method works better.
This trial studies different surgical techniques for treating atrial fibrillation during heart surgery. It may help people with a history of AFib who are already scheduled for open-heart surgery.
This study compares two ways to close off a small heart pouch (the left atrial appendage) to reduce stroke risk in people with atrial fibrillation. The goal is to see which method—surgery or a less invasive tube-based approach—works better and is safer.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
This trial tests a device that helps close the puncture hole in your leg vein after a heart procedure, which may reduce bleeding and help you recover faster.
This study compares a procedure to close a small pouch in the heart (which is a common source of blood clots causing stroke) to using medications alone in people with atrial fibrillation who cannot safely take blood thinners. The goal is to see if this procedure can reduce stroke risk without the bleeding risks of long-term blood thinners.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.